Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Interleukin-2 derivatives

A derivative, IL-2 technology, applied in the field of molecular biology, can solve the problems of ineffective treatment, cell apoptosis, toxic and side effects, etc., and achieve the effect of reducing VLS

Pending Publication Date: 2022-05-06
LETO LAB CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, under the condition of low clinical doses of IL-2, it will preferentially bind to the high-affinity receptors on the surface of Treg cells, which will cause immunosuppression and fail to achieve the therapeutic effect
High doses of IL-2 will neutralize the immune suppression caused by Treg activation by activating a large number of effector T cells, and at the same time, there will be more toxic side effects and cell apoptosis (activation induced cell apoptosis)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Interleukin-2 derivatives
  • Interleukin-2 derivatives
  • Interleukin-2 derivatives

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1I

[0106] The preparation of embodiment 1IL-2 (C125A), IL-2 mutant and IL-2 complex

[0107] In this example, IL-2wt (C125A), IL-2 mutants 1-4 and IL-2 complexes 1-4 were selected for expression respectively, and were purified and prepared by relying on the HPC4 tag attached to the C-terminus of the molecule.

[0108] 1.1 Expression plasmid construction

[0109]Entrust Suzhou Jinweizhi Biotechnology Co., Ltd. to synthesize IL-2wt C125A (SEQ ID NO.74), IL-2 mutant 1-4, IL-2 complex 1-4 (IL-2Pair in IL-2 complex 1~4 and CD25-ECD Pair 1~4), and then perform overlapping PCR to obtain the target fragment according to the operation method mentioned in "Molecular Cloning". Then carry out the recombination connection of the fragment and the pTT5 universal vector, transform DH10B, sequence and bacterium preservation, so as to obtain the required IL-2wt (C125A), IL-2 mutant 1 ~ 4 and the plasmid of IL-2 complex 1 ~ 4 (IL Plasmids of IL-2Pair 1-4 and CD25-ECDPair 1-4 in the -2 complex); o...

Embodiment 2

[0134] Example 2 Determination of the affinity of IL-2wt (C125A), IL-2 mutants 1-4 and IL-2 complexes 1-4 to IL2Rβγ and IL2Rα by biolayer interferomeory (BLI)

[0135] 1. Experimental materials

[0136] The proteins used in the experiment were all produced by Beijing Zhidao Biotechnology Co., Ltd. IL2Rα-his (purchased from Beijing Zhidao Biotechnology Co., Ltd.), IL2Rβγ-Fc (purchased from Beijing Zhidao Biotechnology Co., Ltd.) and IL2 mutants were transiently expressed by HEK293 and parent-child and obtained after purification. Buffer formulation: 10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.1% BSA and 0.05% Tween 20; ProA sensor (Pall Fortebio, catalog #18-5010); HISIK sensor (Pall Fortebio, catalog #18- 5120); the BLI equipment was Octet RED96 produced by Pall Fortebio; data acquisition and analysis were performed using Data acquisition 11.0 and Data analysis 11.0 software, respectively.

[0137] 2. Experimental method

[0138] 1) Preparation of IL2Rβγ-Fc

[0139] Dilute IL2R...

Embodiment 3

[0152] Embodiment 3 promotes the proliferation experiment of T cell

[0153] The CTLL-2 (T cell) proliferation assay is a commonly used assay to measure the activity of interleukin-stimulated immune cells at the cell level. Therefore, the biological activity of IL-2 derivatives was examined here by the proliferation experiment of CTLL-2 cells.

[0154] 1) CTLL-2 cell preparation: the cells were resuspended in culture medium containing FBS and Rat-T-Stim.

[0155] 2) Adding samples: inoculate the cells in a 96-well culture plate, 0.1 ml per well. At the same time, the proteins of the IL-2 derivatives 11, 18, 21 and 28 of the samples to be tested (i.e. the proteins prepared in Example 1) were respectively diluted in multiples, and 0.1ml was added to each well, and each dilution concentration was set in 3 multiple wells. . Separately set up culture solution control wells (100ul cells + 100ul culture solution). 37 degrees, 5% CO 2 Incubate for 72 hours.

[0156] 3) Add MTS: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an IL-2 derivative which partially or completely closes the binding plane of the IL-2 derivative and an alpha receptor subunit by introducing at least one cysteine residue on the basis of IL-2 while substantially retaining affinity for beta and gamma receptor subunit complexes.

Description

technical field [0001] The invention belongs to the field of molecular biology, and specifically relates to an interleukin-2 derivative and a compound thereof. Background technique [0002] Interleukin-2 (IL-2), discovered in 1976 and then known as T-cell growth factor (TCGF), is a globular glycoprotein that plays an important role in maintaining the normal function of T lymphocytes and NK cells . Natural IL-2 is a polypeptide consisting of 133 amino acid residues, with a molecular weight of about 15kD and three cysteine ​​residues located at positions 58, 105 and 125, respectively. Post-translational modifications include Thr glycosylation at position 3, disulfide bond formation at cysteine ​​residues at position 58 and 105, and the formation of four α-helices and some connecting sequences (loop ) composed of high-order structures (Bazan et al., Science 257, 410-413 (1992)). [0003] IL-2 is mainly produced by activated T cells, it can promote the proliferation and diffe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/55C12N15/26C12N5/10C12N15/85A61K38/20A61P37/02
CPCC07K14/55A61K38/00A61P37/04C07K14/7155C07K2319/00A61P37/00A61K38/2013C07K2319/30
Inventor 赵耀彭璐佳郭建云朱笑婷张建军魏婷婷刘慧杰郑茜王冀姝张维
Owner LETO LAB CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com